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Abstract

The auditory temporal processing deficits associated with age-dependent hearing decline
have been increasingly attributed to issues beyond peripheral hearing loss. Age-related hearing
loss (ARHL), also known as presbycusis, is linked with changes in the expression of both
excitatory and inhibitory neurotransmitters in the central auditory system. There are also agerelated changes in the expression and function of the ion channels which mediate action potential
firing. The slow, Ca2+ activated, K+ channels of the BK-type are essential in controlling both
neurotransmitter release and neural communication via alteration of action potential durations,
firing frequency, and neural adaptation. There are many subsets of this type of ion channel located
throughout the body, and though it is evident that these channels are involved in cellular activation
within the peripheral auditory system, little is known about their contribution to auditory
processing in the brain. There is a need for further understanding of the functional involvement
and mechanisms of neurotransmitter loss and how this relates to the BK channel and auditory
disorders such as presbycusis and tinnitus (the perception of a phantom sound). My research
focused on investigating how the downregulation of neurotransmitter production and the
reductions in BK channel expression affect ARHL. I also evaluated a custom BK-channel
modulating peptide as a path towards a possible therapeutic intervention for age-related hearing
loss. This custom peptide is especially useful because it reduces the potential for serious side
effects, due to mechanisms which best mimic natural occurring peptide systems.
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The initial investigation described in this dissertation measured auditory system changes
in aged mice that occurred following a drug-induced increase in the availability of the inhibitory
neurotransmitter GABA. This increase in GABA decreased minimum response thresholds in the
auditory midbrain of aged mice, bringing them to levels seen in young adult animals. The other
changes that occurred following increased GABA availability were increased acoustically driven
neuronal firing rates, frequency-dependent decreases in spontaneous rates, and increases in the
symmetry of the receptive fields. The return of clear and fine-tuned acoustically-evoked responses
in aged mice was a major finding of this experiment.
The second phase of the dissertation built on this demonstration that modulation of the
aged auditory system was possible by changing neurotransmitter levels. This second portion of the
study focused on how a novel potent neuropeptide (LS3), which increases the probability of the
BK channel remaining in the closed conformational state, might invoke alterations in auditoryevoked responses. First, the LS3 neuropeptide was used to modify addictive behavior in the C.
Elegans; followed by evaluation of in vitro changes to a human cell line. This study then confirmed
that LS3 is a potent BK channel modulator with a greater affinity than those known toxins
classified as high-affinity toxins. In vivo testing demonstrated that LS3 could rapidly cross the
blood-brain barrier (BBB) following systemic injections, where it altered auditory evoked activity
in a manner similar to that of the direct application to the dura over the midbrain. This work
demonstrates that the BK channel is highly responsible for the control of auditory-evoked
neurological processes, and that a potent BK channel modulator may be useful for the treatment
of certain neurological disorders.
The third study was designed to confirm that the BK channel plays an important role in
sound-evoked activity generated in the auditory midbrain, by testing the effects of a general BK
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channel pore blocker, PAX. The results established that the BK channel is vital for sound
processing in the midbrain of young adult mice, and is responsible for the maintenance of receptive
field properties. I also evaluated the role it plays in temporal processing, which is an underlying
mechanism for the processing of neurologically-relevant complex acoustic signals such as speech.
Here, blocking of the channel increased (worsened) the threshold for the detection of a silent gapin-noise and the neural recovery functions that occurred following the stimuli.
The fourth study significantly expanded the in vivo testing of the custom peptide channel
blocker, LS3, and added a behavioral measure of changes to auditory perception in addition to the
electrophysiology recordings. The auditory-evoked receptive fields from midbrain neurons were
modulated in a dose-dependent manner following the application of LS3. The neural recordings
took place in the inferior colliculus, where the dorsal region responds to low-frequency sounds and
ventral areas to high frequencies. The LS3-induced suppression or enhancement of evoked
responses was different for the various tonotopic regions of the auditory midbrain. The
improvements shown in receptive fields and improvement in auditory perception indicates a
plausible route for direct translational treatment of auditory disorders through small custom
peptide therapeutics. These studies provide supportive information about how auditory evoked
responses in the midbrain, including the coding of different sound features, are affected by the
down-regulation of a key inhibitory neurotransmitter (GABA), and how GABA-dependent neural
evoked responses are altered in older mice through the modulation of BK channel activity.
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Chapter 1: Introduction

Numerous mechanisms within the nervous system functionally decline as part of the
normal aging process. These declines are multifaceted and are typically described as the loss of
neurons and changes in neurochemistry concomitantly with degradation of their functional
components (i.e. axons, dendrites, and synapses). Genetic, environmental, and age-linked changes
in hormonal, cardiovascular, and metabolic functions also provide additional challenges [1-4]. The
auditory system is no exception in its vulnerability to these and other biological aging changes,
which ultimately leads to degradation in auditory perception, especially in difficult listening
situations such as background noise or reverberation. This collection of maladies is known
clinically as presbycusis, or age-related hearing loss (ARHL). The prevalence of this disorder
ranges from over 30% for adults aged 65-75 years to over 50% for those individuals over 75 [5,
6]. There are two components to ARHL, an increase in peripheral hearing thresholds (particularly
for the high-frequencies) and central auditory processing deficits in spectral and temporal domains.
These combined components result in difficulty understanding speech in noisy environments,
impaired auditory localization, and declines in the processing of auditory information [5, 7-10].
Currently, there are no known interventions to prevent or treat sensorineural hearing loss, which
occurs within the brain.
The main symptom of ARHL is the diminished ability to understand rapid or degraded
speech, as well as speech in noisy environments. These difficulties arise from declines in the ability
to discriminate and extract timing, duration, and frequency cues of relevant acoustic informational
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cues [10]. The central auditory components of ARHL are increasingly studied using functional
imaging techniques, which can map the interconnections between brain nuclei. Many of these have
found a disconnect between auditory regions [11] and their structural integrity [12], though the
source of these breaks is still unknown. The inferior colliculus (IC) is a key auditory nucleus used
in the study of the relationship between the declines in temporal processing and deficits in
peripheral auditory sensitivity [13, 14]. Acoustic information is processed in the IC from
independent pathways in both the ascending and descending directions (i.e. from multiple lower
and higher order nuclei in the brain), as well as those between the cerebral hemispheres [15]. Due
to the complex monaural and binaural processing taking place within the IC [16], studies
examining the age-related changes in various types of auditory processing, for example, temporal
and spectral perception have increased in recent years. The IC is of particular interest, in part
because there is a large body of evidence that show age-related changes in neurochemistry, and
neural processing occur within the IC. These studies include assessing how age affects neural
responses when discriminating between different durations for noise and tonal stimuli [17, 18],
when presented with frequency sweeps [19, 20], and during the detection of silent gaps in noise
[21, 22]. They also indicate that studying the function of the IC over long periods of time may be
useful in identifying key mechanisms in ARHL [10, 23]. Thusly, age-related changes in the IC
will no doubt have an effect on auditory function due to the IC’s pivotal processing position in the
central auditory nervous system, including the coding of complex sounds in quiet and background
noise [24].
Caspary et al. discussed how research has indicated that both synaptic inhibition and postsynaptic regulation within the IC are possible mechanisms for age-related declines in sound
localization and temporal processing [23]. Indeed, there is evidence of an age-related
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downregulation of neurotransmitters found in auditory nuclei throughout the brain [16, 25, 26].
This reduction in the expression of neurotransmitters, both excitatory and inhibitory, may underlie
the functional declines of ARHL and the associated deficits in temporal processing [16, 23, 27,
28]. Another age-related change is in the expression and functionality of voltage-gated ion
channels, which regulate neural transmission through mediation of action potential timing,
duration, and rates of adaptation [29-32].
The ability of the IC to process and transmit auditory information from the brainstem to
ascending nuclei relies on unique neuronal discharge patterns, which are vulnerable to various
insults [33]. Specifically, large-conductance voltage-gated and Ca+-activated K+ (BK) channels
are important in mediating the transmission of acoustically relevant information via control of
spike time and frequency [34-36]. Slice work from the IC of the rat found that blocking these
potassium channels significantly altered the response patterns of neurons by abolishing sustained
firing, lengthening onset spike latencies, and significantly altering spike durations [33]. BK
channels are pivotal in the control of both the fast after-hyperpolarization and repolarization [34]
following an action potential, which alters neural transmission properties. The BK channel is also
highly involved in neurotransmitter release [37, 38], which as described above, is similarly
important for auditory processing and understanding the neural bases of ARHL. BK channel
expression levels vary throughout the central auditory system; expression levels begin to show
high expression within the IC and higher order nuclei with very low to non-existent levels being
found in auditory nuclei caudal to the IC [39].
Objectives of this dissertation include elucidating several of the neural components of
ARHL, with a focus on the alteration of central auditory elements that facilitate synaptic
transmission. In particular, it is anticipated that this research can then further assist in the
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understanding of deficits in temporal processing. The rationale behind this work is that the
mechanisms behind why the neurotransmission of relevant auditory information is diminished in
aging and conditions such as hearing loss, dyslexia, and central auditory processing disorders must
be understood before potential therapeutic interventions can be found and optimized.
1.1 Research Contributions
The research contributions contained within the Chapters and Appendixes C, D, and E are
described here:
1. The first study, contained in Appendix C, describes the effects of increasing the
availability of the inhibitory neurotransmitter GABA, via systemic injection of
vigabatrin (VGB), in the auditory midbrain of old mice. Increasing available GABA
decreased minimum thresholds, altered receptive fields, and increased sound-evoked
firing rates in aged animals. There were also frequency-dependent decreases in
spontaneous rates and increases in the symmetry of the receptive fields following
increased GABA availability. The highlight of this study is the return of clear and finetuned receptive field profiles in aged animals, which resembled those seen in young
adult animals, following the increases in available GABA.
2. The study contained in Appendix D explains the development of a novel potent
neuropeptide and its role as a targeted large conductance Ca2+-activated K+ channel
(BK) channel modulator. We explored the modulation of some of the neural
underpinnings of addictive behavior via a novel neuropeptide (LS3) that modulates BK
channel activity in C. Elegans, along with the in vitro changes induced to a human cell
line. This paper also investigates the alteration induced in auditory evoked potentials
in vivo. In vitro application of LS3 using inside-out patch clamp demonstrates that it is
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a potent BK channel modulator, with a greater affinity than those known toxins
classified as high-affinity toxins to the BK channel. LS3 was also shown to rapidly
cross the BBB following systemic injections where it altered auditory evoked activity
in a manner similar to that of the direct application to the dura of the midbrain. This
work demonstrates that the BK channel is highly responsible for the control of central
auditory-evoked responses, and that a potent BK channel modulator may be useful for
the treatment of neurological or sensory disorders.
3. The study presented in Chapter 4 confirms that the BK channel plays an important role
in sound-evoked activity generated in the inferior colliculus by using a general channel
pore blocker. These experiments confirm that the BK channel affects sound processing
in the midbrain of young adult animals, and show how it compares to the response
properties of aged animals. Blocking the BK channel with Paxilline (PAX) directly
affects maintenance of receptive field properties and modulates temporal processing
through alterations in minimum gap detection thresholds and gap-in-noise recovery
functions. Of note in this chapter is that blocking this ion channel results in the
devolvement of response properties in young adult animals which resemble those seen
in aged animals.
4. The study contained in Appendix E contains data which significantly expands the work
explored in the preceding section (Appendix D) with a focus on the translational
possibilities using in vivo experiments. Here, I found that receptive fields were
modulated in both a dose-dependent and tonotopic manner following the application of
LS3. The improvements in both auditory-evoked midbrain receptive fields and
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behavioral assessments indicates that there is a distinct possibility for small custom
peptides to work as a treatment for auditory disorders.
My work is anchored in using neurological-based biomedical engineering methods to
develop a better understanding of functional declines in the brain and their relation to ARHL. In
summary, the research presented in this dissertation provides new information about how auditory
evoked responses in the midbrain, including the coding of different sound features, are affected by
the down-regulation of a key neurotransmitter, GABA. There is also an analysis of the different
components of auditory responses, how they are altered in older animals, and how they are affected
by modulating the BK ion channel. The results presented provide a significant contribution to the
knowledge base surrounding midbrain processing in ARHL and could facilitate the development
of possible therapeutic treatments to prevent or reverse permanent hearing loss.
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Chapter 2: Increasing GABA Reverses Age-Related Alteration in Excitatory Receptive
Fields and Intensity Coding of Auditory Midbrain Neurons in Aged Mice

Several studies have reported that the age-related changes in central auditory processing
are partially due to alterations in neurotransmitter levels [16, 21, 40-44]. Sensory receptive fields
(RFs) in the auditory system provide information on the thresholds and best response frequency
of neurons, and are primarily formed by the interplay of excitation and inhibition in the auditory
midbrain. The primary inhibitory neurotransmitter in the IC is γ-aminobutyric acid (GABA), and
GABAergic inhibition is thought to sharpen these RFs. GABA receptors alter the signals from
lower order nuclei (i.e. the brainstem) and change how the information is then transmitted to the
thalamus. [33, 45]. The convergence of projections from various auditory nuclei in the IC plays a
critical role in shaping neural responses to sound stimuli by removing noise and sharpening the
processed auditory neural signals [46-49]. Several studies show that reductions in inhibitory
neurotransmitter expression in the central auditory system may contribute to the diminished ability
to process complex sound stimuli observed in ARHL [16, 23, 27, 43, 50, 51]. However, none of
these studies explored the effects of altering GABA while recording evoked responses from the
midbrain. This paper examines the direct relationship between the GABA and ARHL, through
measurements of the evoked responses within the auditory midbrain following the upregulation of
__________________
1

This chapter article is under review for publication in Neurobiology of Aging (Brecht et. al.
Increasing GABA reverses age-related declines in excitatory receptive fields and intensity coding
of auditory midbrain neurons in mice. Neurobiol Aging, 2017.), and can be found in Appendix C.
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GABA. This was carried out via systemic injection of VGB to block GABA transaminase.
Increasing GABA availability altered minimum response thresholds in aged mice, essentially
causing the affected neurons to respond to sound levels that were lower, and at the levels seen in
young animals. This increased GABA availability also increased acoustically driven response
rates, decreased spontaneous rates in a frequency dependent manner, and improved RF symmetry.

8

Chapter 3: A Novel BK Channel-Targeted Peptide Suppresses Sound-Evoked Activity in
the Mouse Inferior Colliculus

Voltage-gated channels of the potassium family mediate the outward flow of the K+
current, thus controlling the hyperpolarization of cells [35, 36]. BK channels are expressed
throughout the body in both neurons and muscle, where they are responsible for modulation of
cellular activity. Blocking the BK channel in vitro can significantly reduce the release of
neurotransmitters [52], broaden the action potential [53, 54], eliminate the fast afterhyperpolarization [34], and reduce firing frequency [55]. Studies have also implicated this voltagegated channel in spike frequency adaptation and the enhancement of neural discharge in many
sensory neural systems [55, 56], which could alter information that is passed from lower order
nuclei in the brainstem and midbrain to higher order nuclei in the cortex [20]. Years of research
into the potential pharmaceutical application of altering BK channel function has been conducted
in regards to treating several different neurological disorders [57, 58]. While there are several
known peptides which can alter BK channel function, until recently [59], there were no
pharmacologically relevant peptides that were amenable to large scale production and had both the
ability to cross the BBB and a high selectivity for the BK channel [36, 60, 61]. A custom derived
9-amino acid peptide, LS3, explored initially by Davis et al. [59] and described within this
__________________
2

The article, (Scott, L.L., et al., A novel BK channel-targeted peptide suppresses sound evoked
activity in the mouse inferior colliculus. Sci Rep, 2017. 7: p. 424-33.), is published in Nature:
Scientific Reports, and can be found in Appendix D.
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manuscript, has a unique action, suppressing the gating of the BK channel rather than blocking the
pore. This paper presents data which indicates that not only does the custom derived peptide, LS3,
change the in vitro probability of both a nematode and a human cell culture derivate of the BK
channel remaining in the open conformational state, but that it also modulates murine auditory
evoked responses in vivo. The study first shows that LS3 can modulate the behavioral assay of
alcohol intoxication and addictive behavior in nematodes. The application of LS3 to C. Elegans
and human cell lines demonstrated that the peptide was a potent BK channel modulator with a
greater affinity than other known high-affinity toxins. LS3 was also shown to quickly cross the
BBB after systemic injection in the mouse, and altered sound-evoked activity in the auditory
midbrain in a way which was similar in magnitude to that found following direct application to the
dural surface of the mouse midbrain. The overall conclusion is that this potent peptide modulator
of the BK channel may be useful for many neurological applications, such as treating
hyperexcitability, convulsions, and seizures, as well as a possible therapeutic for ARHL.
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Chapter 4: Neural Correlates of the BK Channel’s Role in Temporal Sound Processing
Features Within the Inferior Colliculus

In this research, I show that acoustically evoked neural responses can be altered by
modulating the BK channel with a general K+ channel pore blocker, PAX. The use of a specific
pore blocker confirms that the BK channel is critical in the neural coding of auditory information
within the auditory midbrain, and generally in the auditory system (via both systemic and direct
topical administration). The large alterations in sound-evoked driven firing within the midbrain
give confirmation that modulating the main isoform of this ion channel can be beneficial, which
led to further evaluation of LS3 and its family (LS10 LS4) in the study described in chapter 5.
4.1 Introduction
PAX, a fungal tremorgenic mycotoxin, is an indole alkaloid and a known producer of
neurological disorders [62, 63]. While chemicals in these groups seldom cause death, they are
known to disrupt motor activity and cause immobility, and these symptoms are often followed by
convulsions or hyperexcitability [63]. The mechanisms by which these fungal toxins act is not well
understood, but they are suspected to modulate the release of GABA and act as a negative allosteric
modulator of the BK channel [63, 64]. Due to interactions with smooth muscles, PAX was initially
investigated using patch clamp electrophysiology and compared to alternative blockers of the BK
channel which had no real potential as therapeutic agents, such as scorpion toxins and
tetraethylammonium [65], in arterial cell cultures and oocytes [66]. This confirmed that PAX is a
reversible non-selective general BK channel pore blocker [64]. When the BK channel was found
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to be more widely expressed throughout the central nervous system, experiments began to test its
effectiveness in hippocampal slice work [67]. That led to the discovery that blocking the BK
channel in hippocampal slices with PAX could have significant effects on the synaptic
transmission of neurons by regulating action potential [67, 68] and neurotransmitter release [37,
38].
PAX has been tested in vivo as a potential therapeutic treatment for neural hyperexcitability
exhibited during epilepsy and paroxysmal dyskinesia [57, 69]. Sheehan et al. found that in a mouse
model, systemic injection of PAX eliminated the effects of tonic-clonic or epileptic seizures [69].
PAX has also been used to investigate how BK channels contributed to auditory function [70],
specifically those channels located in the sensory cells of the cochlea, inner hair cells [71]. The
BK channels were found to contribute to the shaping of receptor potentials [72] in these inner hair
cells, and blocking the BK channel with PAX had no effect on apical K+ currents within the cochlea
[73]. In animals given intracranial injections of PAX, there was significantly slower learning in
association with pre-pulse inhibition and other training methods using auditory stimuli [74]. Due
to the research demonstrating that PAX can alter both the effects of neurological disorders and
auditory responses, we designed our study to characterize the specific alterations induced in
auditory midbrain neural responses due to this treatment. We applied PAX both topically and
systemically while recording multi-unit activity during the collection of RFs and responses for the
gap-in-noise (GIN) paradigm. Results following blockage of the BK channel function indicated
that this channel directly affects properties of receptive fields. We also found that the BK channel
modulates temporal processing by increasing in minimum gap detection thresholds and gap-innoise recovery functions following PAX treatment.
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4.2 Materials and Methods
The methods summarized here are described in detail in the manuscripts found in
appendices C, D, and E [75, 76].
4.2.1 Subjects
Multi-channel recordings were taken from 9 young (< 7 months) mixed gender CBA/CaJ
mice (longitudinal control). Animals were housed on site 3-4 per cage with litter-mates and kept
near 25°C, on a 12/12 hour light/dark cycle with ad lib water and food pellets. All procedures were
preapproved by the University of South Florida Committee on Animal Resources and are
consistent with US Federal and NIH guidelines under IACUC protocol #0245R.
4.2.2 Surgical Preparation
Surgery and extracellular recordings were collected and analyzed in a method identical to
a procedure used in previous studies [75, 76], appendices C, D, and E. Mice were anesthetized
with an intraperitoneal (i.p.) injection of ketamine and xylazine (100mg/kg and 10mg/kg).
Following anesthesia, the top of the animal’s head and neck was then shaved of fur to prevent
contamination of the incision site. The skin was cleaned, the skull was then exposed, and a small
brass tube was secured to the skull surface along the sagittal suture at bregma with vet bond and
adhered with dental cement. Mice were given a recovery period of 24-48 hours before beginning
the experimental sessions.
4.2.3 Drug Administration
PAX (Sigma, St. Louis, MO, USA), was diluted for topical applications to concentrations
of 1 µM and 0.1 µM in 1% dimethyl sulfate. The dilution of PAX was applied directly to the
exposed IC via a micro-syringe. For systemic administration (i.p) PAX was administered in a
manner following the protocol developed by Sheehan et al. to reach a final in vivo concentration
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of roughly 2.2µg/kg body weight [69]. This protocol resulted in 1 animal/dose /experiment. Fresh
solutions were made prior to each experiment.
4.2.4 Recording Procedures
The right IC was stereotaxically located [77] and exposed via a small (<1.0 mm)
craniotomy. Multi-unit extracellular activity was recorded using vertically oriented single shank
silicon acute penetrating 16-channel electrodes. The IC was mapped and a location which yielded
at least 10 active channels and was within the central portion of the topographic map was chosen
as the recording location for the experiment. Recording sessions lasted an average of 6-8 hours,
and if at any time a mouse showed signs of discomfort, such as excessive movement, it was
removed from the apparatus and testing was halted.
4.2.5 Stimulus Generation and Presentation
RFs from all active channels were acquired in response to tone burst stimuli presented from
0 to 80 dB SPL in 5 dB steps and from 2 to 64 kHz, for a total of 2125 frequency and intensity
combinations that were presented pseudo-randomly to the contralateral hemifield 5 times. For each
RF, the best frequency (BF), the minimum threshold (MT), maximum driven rate, and spontaneous
rate were recorded. The distance between the speaker and the pinna was fixed at 22.5 cm.
GIN signals were used to assess temporal processing and consisted of wide band noise
bursts presented at 70 dB SPL with embedded silent gaps having durations from 1 to 96 ms,
presented via the free-field speaker, replicated 10 times for each gap duration. Minimum gap
detection thresholds (MGTs), PSTH response patterns, and recovery functions were analyzed prior
to and following application of PAX (recording post-PAX continued up to 5 hours).
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4.2.6 Spike Sorting
Spike waveforms were processed in MATLAB® using the TDT OpenDeveloper ActiveX
controls and passed to AutoClass C v3.3.4, an unsupervised Bayesian classification system that
seeks a maximum posterior probability classification, developed at the NASA Ames Research
Center [78, 79]. Once the classes had been determined in each channel of data, they were visualized
within a custom MATLAB® program and assigned to multi-unit, single-unit, or noise classes.
Event classes which were categorized as noise were subsequently discarded. As recorded activity
from most channels was elicited from the spiking of two or more neurons, all recordings units in
this paper were considered multi-unit activity [80]. Nonetheless, there was no observation of any
consistent differences in the RFs between single units and multi-unit clusters.
4.2.7 Data Analysis
RFs were analyzed using a custom MATLAB® program which classified tuning using a
method similar to that used to classify neurons in the primary AC [81]. The RFs were sorted into
V-shaped, multi-peak, primary-like, and closed/complex by investigators that were blind to the
age of the animal from which the recording was made. The frequency at which driven activity is
responsive at the lowest intensity (threshold) is classified as the characteristic frequency (CF) and
the point in the receptive field that elicits the maximally driven activity is categorized as the BF.
A custom MATLAB® program was used to calculate the edges of each channel’s RF, and this was
verified via visual inspection to ensure no non-driven activity was included in the calculation. The
change in the driven response due to treatment was further examined when collecting total induced
spike rate-level functions derived from within the boundary of each RF. This was done by
calculating the total number of events in response to a 25 ms CF tone presented from 0 to 80 dB
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SPL, in 5 dB steps, and examining the summed spikes per presentation at each intensity. From
each of these RF presentations, total spike counts were calculated.
Statistical analysis and graphs were generated using GraphPad Prism version 6.01 for
Windows (GraphPad Software, La Jolla, CA). Most these results are presented using box plots,
which allow for mean, median, and the distribution of the data to be denoted. A one-way ANOVA
test and Tukey’s repeated measures analysis procedure were used to evaluate the effects of PAX
on the RF properties of MT and mean driven rates. A two-way ANOVA and Bonferroni’s repeated
measures test were used to evaluate divergent effects of PAX on the maximum and total evoked
spikes counts, while a Chi-squared test was performed to evaluate whether the frequencies of the
RF types differed from the proportion of frequencies that would be expected by chance. Alpha was
set at 0.05 for all statistical tests.
4.3 Results
RFs were obtained from multi-unit activity prior to and following application of 1 µM (58
units) or 0.1 µM (64 units) PAX. For each recorded unit, a full RF was collected and further
classified according to its characteristic shape based on accepted classifications. Figure 1 shows a
representative RF which was recorded during an IC penetration, with the boundaries of the
excitatory region marked by the dashed white line. The MT was determined as the minimum sound
level intensity in which a pure tone evoked a neural response. The maximum spike rate was
calculated as the largest number of spiking events that were recorded in response to a pure tone
stimulus, and this point was then utilized to determine the BF.
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Threshold

Figure 1. Representative example of an auditory evoked excitatory RF from an IC neuron
before blocking the BK channel. Firing activity (as count) is plotted as a function of frequency
vs intensity. The color map represents the response strength in spikes/presentation or repetition.
Bandwidth was measured using the Q factor at 10, 20, 30, and 40 dB above MT. This is considered
a V-type RF, which accounts for the majority of RFs in the IC.

Figure 2 shows representative examples of four different RFs during the initial baseline
(control) recordings in the far-left panels, and changes in the RFs following topical treatment with
1 µM PAX, taken at one hour time points, as shown in the panels to the right. While there were
overall observed response differences between individual neurons, they fell into 2-3 main response
types. As shown in Figure 2a, some units completely lost responsiveness to the auditory stimuli
and dissipated into random spontaneous activity, i.e., a complete lack of an evoked response. The
majority of other units followed the examples shown in Figures 2b and c, where the response edges
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didn’t completely disappear, though the MTs significantly increased and the overall driven rates
significantly decreased. Figure 2a shows the loss of selectivity, 2b shows a decrease in both MT
and driven rate, and 2c displays a decrease in sharpness of tuning of the RF.

Figure 2. Representative examples of RFs collected prior to and for 5-hours following PAX
administration. Initial control conditions are shown in the far-left panels, these are followed by
RFs taken every hour up to 5 hours post-application application of PAX. Note that the RFs are not
scaled to the same maximum spike rates. Although there were differences between the RFs of
individual neurons, for all administration methods and dosage experiments (a, b, & c) the MT
increased. Panel (a) shows a loss of selectivity, (b) shows a decrease in both MT and driven rate,
and (c) displays a decrease in sharpness

4.3.1 Paxilline Increases the RF Minimum Threshold
The overall effect of topical PAX application on MTs is shown in Figure 3. There were
significant differences in mean minimum thresholds between PAX treated and baseline control
units for both topical application concentrations, with treated units exhibiting a statistically higher
(worse) MT. Immediate threshold increases of 21 dB [F (25, 632) = 27.39, p < 0.0001] and 19.5
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dB [F (27, 840) = 41.88, p < 0.0001] occurred within an hour of the 1 µM and 0.1 µM PAX
application, respectively, and were maintained for at least six hours.

Figure 3. The change in minimum thresholds following application of PAX. Box plots show
the mean (denoted by the cross), and median (solid line). Blocking BK channels caused an
immediate increase in minimum thresholds at the BF. There was a significant increase in threshold
from baseline (blue) following topical application to the IC of both 1 µM PAX (ANOVA:
F=27.39), p<0.0001), shown on the left, and 0.1 µM PAX (ANOVA: F=41.88), p<0.0001), shown
on the right. At 1 µM the mean threshold increase was ~40 dB and for 0. 1 µM the effect decreased
to ~20 dB.

4.3.2 Paxilline Decreases the Maximum Driven Activity Rate
Application of PAX resulted in a near-immediate decline in a neuron’s maximum driven
rate to tonal stimulation, measured at the BF, of 97% and 94% respectively and produced stable
BF shifts towards lower frequencies for over 6 hours, regardless of the PAX concentration. As
shown in Figure 4, the application of 1 μM PAX significantly decreased the mean evoked spike
rates by 2.3 spikes/stimuli [F (12, 422) = 27.79, p < 0.0001], from a control rate of 2.6
spikes/stimuli. The 0.1 μM concentration also resulted in dramatic decreases, from 2.4 to 2.1
spikes/stimuli [F (13, 443) = 17.11, p < 0.0001].
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Figure 4. The change in maximum driven rate following topical application of PAX. The
maximum firing rates over a 25 ms duration were taken at the BFs, driven rates were significantly
reduced up to 6 hours following application of both 1 µM (N = 58, ANOVA: F = 27.79, p<0.0001)
(left) and 0.1 µM (N = 64, ANOVA: F = 17.11, p<0.0001) (right) PAX to the IC.

Following systemic administration of PAX, there was a significant decrease in driven rate
from 2.6 to approximately 1.7 spikes/stimuli [F (6, 105) = 3.451, p < 0.0038], shown in Figure 5.
The mean evoked spike rates significantly decreased in a time-dependent fashion, in the range of
0.6 to 1.1 spikes/stimuli, with an overall mean decrease rate of 0.9 spikes/stimuli. This observed
decrease is approximately half of the decline in driven rate following the topical application
discussed above and is likely due to the dosing which was selected based on previous work
showing that a systemic dose of 4.4 ng/kg PAX significantly reduced the intensity and duration of
seizures induced via pentylenetetrazole injection [69].
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Figure 5. The change in maximum driven rate following systemic administration of PAX.
The maximum firing rates collected from the RF at BF over a 25 ms window are plotted as a
function of time following system administration of PAX. These rates were significantly reduced
up to 6 hours following systemic administration of 4.4 nG (N = 16, ANOVA: F = 3.451, p<0.0038)
PAX.

4.3.3 Representative Peri-stimulus Time Histograms (PSTHs)
PSTHs are used to classify the temporal response patterns to steady state stimuli of auditory
system neurons into phasic or tonic categories [18]. PSTHs were classified from responses elicited
by the GIN paradigm, where noise bursts are used to generate the activity. The GIN stimuli also
included silent gaps of various duration in noise (see Methods). Classifications were based on the
temporal discharge pattern in response to both noise bursts (NB1 & NB2), and divided into the 9
categories described by Blackburn et al. and Le Beau et al. [82, 83]. These classes involve two
general categories: phasic units which discharge at either the stimulus onset or offset and rapidly
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cease discharging, or tonic units which discharge continuously [18]. Onset units indicate firing
only at the onset of the noise burst, and are further divided into three categories depending on the
duration of the response. Onset units which respond to the onset of the noise burst and followed
by a termination in response made up 21.3% of units. On-fast (22.8% of units) and on-slow
(17.3%) units had a similar initial clear response to the noise burst, but unlike the onset unit, were
followed by a longer response before discharge ended. Primary-like units have a robust discharge
to the onset of the noise burst and then gradually lower to a steady response, and made up 21.3%
of responses. Sustained units (6.3%) discharge throughout the noise burst, and on-pause (5.5%)
units have a clearly defined onset to the noise burst followed by a cessation in discharge, then a
return in unit discharge. On-off units exhibit a clear response to the onset and termination of the
noise bursts and made up approximately 2.3% of the total response types observed. Examples of
the most common PSTH response types are shown in figure 6, along with the overall distribution
of all classification types derived from the cumulative PSTHs for all gap durations.
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Figure 6. PSTH classification types. Classification was based on the temporal discharge pattern
in response to both noise bursts (NB1 & NB2). The y-axis contains the total spike count, combined
from each repetition of the stimuli containing a unique gap length. The x-axis shows the time from
the onset of the first noise burst to the offset of the second noise burst. The PSTHs included several
phasic types: the onset type, which displayed only a transient response to the signal onset; on-slow
and on-fast, similar to the on type but displaying a low-level response throughout the duration of
the stimulus; and on–off, which discharges to both the onset and offset of the signal. The tonic
response types were the primary-like, which displays a fast-adapting evoked response at the
stimulus onset, followed by a strong sustained component, and the sustained, which is similar to
the primary-like but does not show a prominent initial phasic response. Representative response
types are shown here, along with the overall distribution of classifications derived from the
cumulative PSTHs for all gap durations in the top right panel.
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4.3.4 Paxilline Alters Temporal Response Patterns (PSTHs)
The data illustrated in Figure 7 shows the overall reduction in cumulative sustained firing
observed across all PSTH response patterns types, elicited by noise burst stimuli at one-hour time
points following the application of PAX. The cumulative PSTHs were computed by combining
the unique responses from each of the 10 replications at all gap durations. The reduction in
sustained firing was also accompanied by a decrease in the total driven rates. The red line denotes
initial pre-application firing activity, with post-PAX application represented by colored overlays.
The largest decrease in driven activity was observed for units which exhibited the sustained firing
activity during the entire noise burst (NB), like those of the primary-like, sustained, and on-slow
units. Onset or phasic units with rapid decreases in spiking following NB onsets demonstrated a
smaller post-PAX reduction in sound evoked driven rate when compared to units with sustained
responses, a finding that is also evident in the recovery functions which will be explored later in
the chapter.
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Figure 7. Effects of PAX on cumulative gap PSTHs over time. The red line denotes the initial
pre-application responses, with post-PAX application responses represented by colored overlays.
This data illustrates the reduction in the sustained firing observed for all unit types, along with the
overall reduction in total driven spikes. The largest decreases were observed for response type
units which exhibited sustained firing activity during the entire noise burst (NB). Units with rapid
decreases in spiking following NB onsets demonstrated a smaller post-PAX reduction in sound
evoked driven rate when compared to units with sustained responses, a finding that is also evident
in the recovery functions.
4.3.5 Paxilline Application Alters GIN Recovery Functions
Blocking the BK channels with PAX systematically prolonged the recovery functions of
multi-unit responses with on-fast and primary-like PSTH response patterns, shown in Figure 8.
Driven rate in response to both NBs significantly dropped 90+% from baseline after 3 hours.
However, when we normalized the recovery functions to baseline, neural coding of the silent gap
did not show a significant deficit, as seen in figure 9. Tonic units which contained an extended or
sustained excitatory drive, such as primary-like, on-slow, and sustained, showed deficits in

25

temporal coding which lasted the duration of the experiment, shown in figure 10. This contrasts
with the phasic or rapidly responding units, such as those with onset or on-fast responses.

Figure 8. Effects of blocking BK channels on representative multi-unit responses with onfast and primary-like PSTH patterns. Recovery functions are plotted as spike counts as a
function of gap duration. Driven rates systematically declined over 3 hours for all tested units
following application of PAX. For all PSTH response patterns, the response to both NBs dropped
90+% from baseline after 3 hours.

Figure 9. Effects of blocking BK channels on normalized gap recovery functions for multiunit responses with on-fast PSTH response patterns. Recovery is normalized to the spike count
elicited by NB1 and plotted as a percent of the response. Despite the decline in overall driven rate
following PAX application, temporal coding of silent gaps did not show significant reductions
over this same time course for on-fast units.
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Figure 10. Effects of blocking BK channels on normalized gap recovery functions for multiunit responses with primary-like PSTH response patterns. Recovery is normalized to the spike
count elicited by NB1 and plotted as a percent of the response. There was an immediate reduction
in the driven activity, consistent with all recorded unit types. This response type also exhibited a
decrease in the temporal coding of gaps, which lasted over the course of the experiment.
4.3.6 Paxilline Alters Temporal Processing
Evoked responses to both noise bursts of the GIN paradigm were totaled, and the MGT
was calculated as the gap duration which induced a 50% decrease in the evoked response during
the silence, and a 50% increase at the onset of the second noise. The MGT was only counted if this
occurred in both the gap length identified and the next two larger gap durations. Neural responses
to the GIN stimuli exhibited an average pre-drug MGT of 6 ms. MGTs increased post-PAX,
regardless of concentration level, and were correlated with a systematic decrease in driven activity
to both the pre- and post-gap carrier over time, Figure 11. The mean MGT significantly increased
from 6 ms (M = 5.928 SEM = 0.9858) to approximately 12 ms (M = 11.01 SEM = 1.962) within
1 hour of PAX application, then reached approximately 20 ms (M = 20.16 SEM = 3.66), which
was maintained over the course of the experiment.
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Figure 11. Minimum gap detection thresholds (MGTs). MGTs were significantly increased at
all time points following PAX application. (**= p<0.005, ****= p<0.0001).

4.4 Conclusions
These results suggest an important role of BK channels in the formation and maintenance
of receptive field properties and temporal coding in auditory midbrain neurons. Preliminary data
indicates that expression of BK in the aged IC is down-regulated (Appendix E Brecht et al. 2017
in preparation) and therefore may be a factor in contributing to the central auditory processing
deficits found in aged listeners. There is evidence that the BK channel plays a key role in the
neuron’s ability to repolarize following excitation, which allows for it to respond to subsequent
driving stimuli. These results suggest that BK channels are involved in both the maintenance of
auditory midbrain response thresholds, receptive field sharpness of neurons, and initiated soundevoked neural activity. The loss of sound-evoked driven response results in deficits in temporal
processing as indicated by the alterations in MGTs and GIN recovery functions. Results are
consistent with in vitro studies showing that BK channel antagonists can modulate evoked firing
patterns. This is the first study showing that modulating BK channels alter neural coding of sound
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processing in vivo. Further research into the role of BK in forming excitatory RFs was examined
through targeted blocking, using custom peptides, which form and control the channel kinetics,
and is discussed in later chapters. This will allow for the possible delivery of drugs specific to the
BK channel.
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Chapter 5: Neural Correlates of Central Auditory Processing can Be Improved by a BK
Channel Targeted Peptide in the Aged Auditory System

The BK channel has been implicated in high-frequency hearing loss [84, 85] resulting from
dysfunction of receptor cells in the peripheral auditory system. This is due to the BK channel’s
involvement in shaping sound-evoked potentials from outer hair cells within the cochlea [86]. This
channel is thought to determine the resonance frequency of hair cells (the sensory cells of the
cochlea), in part due to the specific number of these channels located on the cells and their kinetics
[87]. Thus, studies of hair cell-specific deletion of the BKα subunit indicate that humans with a
partial or complete functional loss of BK channels would suffer from ataxia (loss of voluntary
muscle control), increased susceptibility of outer hair cells to noise trauma, and auditory
processing disorders [88]. However, increased excitability and precision in temporal coding
following hair cell-specific deletion of the BKα subunit has been observed [88]. It was also found
that knockout mice demonstrated no impairment in cochlear function when tested using auditory
brainstem responses [84]. Testing of other genetically modified mice has shown delayed
association of auditory stimuli with an air-puff [89], delayed learning of pre-pulse inhibition, and
declines in startle amplitudes [74]. While most research into the functional role of the BK channel
on hearing focuses on the peripheral system, it has been shown that expression of the BK channel
__________________
The article “Age-related central auditory processing can be improved by a BK channel targeted
peptide” is in preparation for publication submission, and can be found in Appendix E.
3
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also varies throughout central brain regions [39, 62]. My research hopes to bypass the possible
confounds of utilizing a knockout mouse in which alternative K+ channels may be upregulated to
compensate for the decrease in BK channels, by directly modulating the existing BK channels.
This paper shows that not only does the modulation of the BK channel within the auditory midbrain
affect acoustically evoked neural responses in a manner like those observed with a channel blocker,
but it does so in a way not seen before. This study also shows that evoked responses modulated by
the custom derived peptide, LS3, were dependent on the frequency of the test stimuli, which was
then replicated in behavioral assays of auditory perception.
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Chapter 6: Summary of Results and Future Works

This dissertation advances our understanding of the neural correlates of ARHL by
answering several questions related to the decline of neural function and sound-evoked response
properties of the central auditory system, specifically within the auditory midbrain. The inferior
colliculus was selected for this study because of the large body of current research which
implicates it as a pivotal region of interest for the study of ARHL. Specifically, there are many
studies demonstrating changes in the neurochemical makeup of GABAergic circuitry connections
and expression during aging [16, 23, 41, 90-94]. There is also evidence that the BK channel is
highly expressed within the central auditory system at the level of the inferior colliculus [39], and
that the BK channel is at least partly responsible for the control of neurotransmitter release [38,
52, 72, 95-98] and therefore neural activity.


The first chapter answers the question: Can we alter hearing in an aged animal?
Here it was shown that increasing available GABA within the synaptic cleft via systemic
administration of VGB reverses the age-related down-regulation of GABA can, in fact,
improve hearing in aged animals.



The second chapter focused on determining if the BK channel could be directly modulated
with a targeted peptide, LS3. Here, it was shown that LS3 modulated the BK channel for
both in vitro and in vivo applications. Experiments conducted by our collaborator, Dr. Luisa
Scott, on the nematode and in human cell cultures found that LS3 altered the probability
of opening of the BK channel, where it specifically acts as a potential channel closer.
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The third chapter addresses the possibility of directly modulating the BK channel in the
auditory midbrain in an in vivo mouse model via the topical and systemic application of
PAX, a BK channel pore blocker. PAX altered acoustically evoked neural responses when
administered both topically and systemically, by completely abolishing sound-evoked
activity. This produced a cascade of effects that disrupted receptive fields, intensity coding,
and the temporal coding of sound.



The final chapter expands on the results of the preceding chapters and addresses the
potential therapeutic applications of modulating the BK channel. The chapter’s major
results are that the BK channel is present in the mammalian auditory midbrain and that
there are changes in the expressional level of this ion channel during aging. The
experiments conducted in the murine model show that there is a significant downregulation of the mRNA expression levels of BK with age, and modulating its activity can
not only alter acoustically-evoked neural responses, but can improve salience of acoustic
stimuli as measured through behavioral responses.
Overall, this dissertation shows that the aged auditory system can benefit from an increase

in GABA following treatment that increases availability of GABA within the synaptic cleft, and
that neural function can be improved. It then establishes that the BK channel is a promising
pharmacological target for many neurological applications, and shows that it plays an important
role in auditory processing. My research demonstrates for the first time, via pore blockage with
PAX, that the BK channel plays a pivotal role in regulating neural response patterns and temporal
coding. Finally, my dissertation presents evidence that a small peptide could similarly modulate
auditory responses without the potential side effects of non-selective targeting.
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6.1 Pharmacological Implications
The first study uses VGB, a drug which we found significantly improved various response
properties (minimum threshold, driven rates, and frequency selectivity among others) of aged
animals. However, the mechanisms underlying how GABA is increased with this drug are
functionally different from other GABA-modulating compounds. VGB was originally considered
as a potential treatment for epilepsy [99], although it was later discovered that treatment could
cause deficits in the peripheral visual field for over 30% of pediatric patients [100, 101]. This
means that despite the therapeutic promise of VGB-induced improvements in the filtering of RFs,
which lead to increased sound evoked driven rates and decreased spontaneous activity, the sideeffects associated with VGB preclude this drug from being used for human patients. Other drugs
which increase GABA levels within the central nervous system of humans more effectively, like
gabapentin [21], could potentially fulfill this goal.
Similarly, modulation of the BK channel may ultimately be a target for a therapeutic
treatment for ARHL. However, most highly selective channel modulators such as
tetraethylammonium, PAX, iberiotoxin, penitrem A, and charybdotoxin, are neurotoxin deviants
taken from potent toxins and venoms [102]. Most of these toxins have complex structural makeups
and are hence not suitable for synthesis on a large-scale basis, and will likely have a diminished
ability to cross the BBB [76]. Due to the complex structures inhibiting transport across the BBB,
many BK channel-targeting peptides require a lethal dose of administration to be effective [103].
Peptides are already the normal communication messengers within the nervous system and
comprise hormones, ligands, neurotransmitters, and other compounds. This makes them ideal for
functioning as a novel modulator of the auditory system. Custom peptide drugs have the same
potential for high affinity and specific binding to ion channel targets as seen with many
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neurotoxins, though with a likely increased ability to cross the BBB because of their similarity to
current messengers [76]. Custom designed peptides also have the potential to be highly specific to
select isoforms of ion channels, unlike most toxins, which are non-selective for all variants [102,
103]. This specificity becomes necessary for targeted BK channel treatments without affecting
alternative systems [104], because of the large number of transcription variants [97, 102] and the
differences in expression levels throughout the brain [39].
6.2 Study Limitations
Elucidating the causal point of the effects comes with some difficulty due to the different
methods we used to administer the peptide, local versus systemic. It is surprising that both types
of administration produced similar main effects, albeit at different dosages. This finding
overcomes one of the major hurdles in central nervous system drug development, crossing the
BBB [105]. Another major obstacle in treatment of central nervous system disorders is specific
targeting for intervention and packaging of these targeted drugs. In order for a molecule to pass
the BBB, it must be small, less than 400-500 Da, and have a high lipid solubility [105]. However,
simply being a small molecule does not guarantee the molecule will cross the BBB, and most
packaging systems, including elastin-like polypeptides and hydrogels which protect the treatment
molecules from phagocytic activity [106] can also increase the molecular weight, thus preventing
them from crossing the BBB. While some of these methods show promise by accumulating in cell
bodies [107], this does not ensure that the molecule can pass the BBB as size and specific uptake
mechanisms become the limiting factors [105, 108]. Other high-affinity compounds such as
nanoemulsions and polymeric nanoparticles could potentially carry peptides, however, because
their size can vary with the payload it does not ensure successful BBB transfer [108, 109]. To
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improve treatment options, many of these methods could be studied and potentially used to
package the peptide and provide for local, targeted delivery.
There is also the possibility that caudal brainstem centers might have contributed to our
results. In order to rule this out, we analyzed P1 and P4 amplitudes from the auditory brainstem
response following systemic administration of both PAX and our neuromodulating peptide, LS3
(Appendix E: Brecht et al. 2017 in preparation). There were no changes in excitatory drive from
the auditory nerve or lateral lemniscus, as measured with input/output amplitude functions. This
is most likely tied to the low expression levels of the BK channel isoforms found within the
auditory nuclei of the brainstem [39]. Studies of the cochlea have also found that there is little to
no BK channel current or immunoreactivity in the low-frequency regions, but it is highly expressed
in the high frequencies [73]. However, there were changes in electrophysiological responses from
the auditory midbrain, which is the first location of the central auditory system to show high
expression of the BK channel [39]. While it is not possible to say that there is no effect from
alterations in signal processing or output in caudal nuclei, the fact that the auditory brainstem
responses were not altered makes this conclusion more likely. However, because there are also
high expression levels of the BK channel within the thalamus and cortex [39], effects from these
regions are harder to rule out. Similarly, recording from the IC typically results in responses
classified as multi-unit, which means these responses can be made up of activity from several
different cellular types [110]. To determine the exact location of modulation and cellular responses
in the future, patch-clamp recordings from brain slices could be used to indicate the exact cell type
and its associated response.
Patch-clamp recordings would also be beneficial in illuminating where the BK channels
are present on the responding cell. The BK channel can be found on both pre- and post-synaptic
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nerve terminals of neurons, and thusly exerts control over the excitatory–inhibitory balance of
neural responses [72, 97]. These variations in terminal locations may be a factor in the tonotopic
variations observed following LS3 application (Appendix E, Brecht et. al 2017, in preparation).
To eliminate any time-dependent diffusion effects and to better localize treatment to specific cell
types and layer locations within the auditory midbrain, future studies should consider additional
delivery methods such as micropumps or iontophoretic delivery systems. These delivery methods
could also clarify if there are any recruitment or facilitatory effects associated with selectively
modulating specific frequency regions, as specific layers can be targeted for drug delivery.
While the most exciting and novel findings from this research culminate in the ability to
increase low-frequency responses of the auditory midbrain, this region is not that which is most
commonly associated with ARHL. However, declines in responses from low-frequency hearing
region do occur and likely contribute to complex sound processing deficits observed in the aged
listener. While these declines are typically not as severe, they can be more detrimental to tasks
such as picking out specific voices in a noisy environment than losses associated with highfrequency regions. Even though the amount of benefit associated with the low-frequency gains
could be significantly debated, a small improvement in responses properties, especially audibility,
is considerably better than no improvement. These small improvements may also be a mechanism
in the threshold improvements observed following LS3 application. Within the IC, neurons within
specific layers fire in response to their CF, and neurons with similar CF may fire in synchrony,
resulting in increases of the overall driven rates and improvements in the structure of the receptive
field response [111, 112]. Again, future studies utilizing direct regional application and patchclamp studies of specific neural types would be beneficial in identifying the exact modes of
alteration observed within this research.
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Appendix A: Abbreviations

Inferior Colliculus

IC

Receptive Field

RF

Paxilline

PAX

Peri-stimulus time histogram

PSTH

Age-related hearing loss

ARHL

γ-Aminobutyric acid

GABA

Gap-in-noise

GIN

Minimum Gap Detection Threshold

MGT

Minimum Threshold

MT

Characteristic Frequency

CF

Best Frequency

BF

Noise Burst

NB

First Noise Burst

NB1

Second Noise Burst

NB2

Vigabatrin

VGB

Blood-Brain Barrier

BBB
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Appendix C: Increasing GABA Reverses Age-Related Declines in Excitatory Receptive
Fields and Intensity Coding of Auditory Midbrain Neurons in Mice

Appendix C contains the manuscript titled, “Increasing GABA reverses age-related
declines in excitatory receptive fields and intensity coding of auditory midbrain neurons in mice”,
which is under a second review by Neurobiology of Aging.
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Appendix D contains the manuscript titled, “A novel BK channel-targeted peptide
suppresses sound evoked activity in the mouse inferior colliculus”, published by Nature: Scientific
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Appendix E contains the manuscript titled, “Age-related central auditory processing can
be improved by a BK channel targeted peptide”, which is in preparation for submission.
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